Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Ferroptosis inducer

DRUG CLASS:

Ferroptosis inducer

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

GSK3B overexpression	Breast Cancer	GSK3B overexpression	Breast Cancer	erastin Sensitive: D – Preclinical erastin Sensitive : D	erastin Sensitive: D – Preclinical erastin Sensitive : D
SLC3A2 expression	Prostate Cancer	SLC3A2 expression	Prostate Cancer	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D
GPX4 expression	Prostate Cancer	GPX4 expression	Prostate Cancer	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D
SLC7A11 expression	Prostate Cancer	SLC7A11 expression	Prostate Cancer	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D	RSL3 Sensitive: D – Preclinical RSL3 Sensitive : D
GPX4 expression	Prostate Cancer	GPX4 expression	Prostate Cancer	erastin Sensitive: D – Preclinical erastin Sensitive : D	erastin Sensitive: D – Preclinical erastin Sensitive : D
SLC3A2 expression	Prostate Cancer	SLC3A2 expression	Prostate Cancer	erastin Sensitive: D – Preclinical erastin Sensitive : D	erastin Sensitive: D – Preclinical erastin Sensitive : D
SLC7A11 expression	Prostate Cancer	SLC7A11 expression	Prostate Cancer	erastin Sensitive: D – Preclinical erastin Sensitive : D	erastin Sensitive: D – Preclinical erastin Sensitive : D
ACSM3 overexpression	Prostate Cancer	ACSM3 overexpression	Prostate Cancer	erastin Resistant: D – Preclinical erastin Resistant : D	erastin Resistant: D – Preclinical erastin Resistant : D
ACSM3 overexpression	Prostate Cancer	ACSM3 overexpression	Prostate Cancer	ML210 Resistant: D – Preclinical ML210 Resistant : D	ML210 Resistant: D – Preclinical ML210 Resistant : D
ACSM1 overexpression	Prostate Cancer	ACSM1 overexpression	Prostate Cancer	ML210 Resistant: D – Preclinical ML210 Resistant : D	ML210 Resistant: D – Preclinical ML210 Resistant : D